Exicure (XCUR) Enterprise Value Growth (1y) (2017 - 2026)
Exicure (XCUR) Enterprise Value Growth (1y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Exicure |
19.38 Mn |
16.77 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
75.01% |
| Dec 31, 2025 |
70.05% |
| Sep 30, 2025 |
-1,193.88% |
| Jun 30, 2025 |
-1,388.26% |
| Mar 31, 2025 |
-2,746.99% |
| Dec 31, 2024 |
-520.44% |
| Sep 30, 2024 |
62.80% |
| Jun 30, 2024 |
77.39% |
| Mar 31, 2024 |
96.33% |
| Dec 31, 2023 |
79.38% |
| Sep 30, 2023 |
94.11% |
| Jun 30, 2023 |
89.48% |
| Mar 31, 2023 |
62.25% |
| Dec 31, 2022 |
75.02% |
| Sep 30, 2022 |
74.28% |
| Jun 30, 2022 |
60.41% |
| Mar 31, 2022 |
60.88% |
| Dec 31, 2021 |
52.31% |
| Sep 30, 2021 |
35.33% |
| Jun 30, 2021 |
34.65% |
